Clinical TrialID 3559
Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
NCT01371058
Coronary Artery Disease
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 3559
- Evidence Id
- 3559
- Core Evidence Id
- 3559
- Source Clinical Trial Id
- 3533
- Herb2 Clinical Trial Id
- HBCT003533
- Nct Id
- NCT01371058
- Title
- Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
- Status
- Completed
- Phase
- Phase 4
- Study Result
- No
- Study Condition
- Coronary Artery Disease
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
- Intervention
- DRUG: high maintenance clopidogrel|DRUG: routine dual antiplatelet|DRUG: policosanol plus dual antiplatelet
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Prevention
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 350
- Outcome Measure
- reversion rate of HPR, reversion was defined as platelet aggregation \<65%, 30 days
- Sponsor Collaborator
- Shenyang Northern Hospital
- Funded By
- OTHER
- Location
- The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China
- Other Id
- NH-20110530
- Start Date
- 2011-03
- Primary Completion Date
- 2012-09
- Completion Date
- 2013-09
- First Posted
- 2011-06-10
- Results First Posted
- Last Update Posted
- 2015-12-16
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01371058
- Title Cn
- Title En
- Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
- Bilingual Status
- semi_complete